BeyondSpring (NASDAQ:BYSI – Get Free Report) is projected to issue its Q3 2026 results before the market opens on Thursday, November 12th. Analysts expect the company to post earnings of ($0.54) per share and revenue of $8.77 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Friday, November 13, 2026 at 4:00 PM ET.
BeyondSpring (NASDAQ:BYSI – Get Free Report) last released its earnings results on Friday, August 14th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.54) by $0.52.
BeyondSpring Trading Up 9.3%
Shares of BYSI stock opened at $0.68 on Thursday. The company has a market cap of $27.92 million, a price-to-earnings ratio of -5.66 and a beta of -0.12. The stock has a 50 day simple moving average of $0.66 and a 200-day simple moving average of $1.26. BeyondSpring has a 12-month low of $0.42 and a 12-month high of $2.44.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded BeyondSpring from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, October 8th. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock has an average rating of “Sell”.
Get Our Latest Stock Analysis on BYSI
BeyondSpring Company Profile
BeyondSpring Inc (NASDAQ: BYSI) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer and other serious diseases. The company’s lead product candidate is plinabulin, a small-molecule agent designed to provide both anticancer and immune-modulating effects.
Plinabulin has been investigated as a treatment to prevent chemotherapy-induced neutropenia, a potentially serious reduction in infection-fighting white blood cells that can occur during cancer treatment.
Featured Stories
- Five stocks we like better than BeyondSpring
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
